|
erythromycin A |
|
CHEBI:42355 |
|
An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
CHEBI:112506, CHEBI:42352, CHEBI:4841, CHEBI:4843, CHEBI:23950, CHEBI:28672
|
|
eMolecules:2725491, eMolecules:2725679, eMolecules:29917758, eMolecules:6842882, ZINC000085534336 |
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C37H67NO13/c1- 14- 25- 37(10,45) 30(41) 20(4) 27(39) 18(2) 16- 35(8,44) 32(51- 34- 28(40) 24(38(11) 12) 15- 19(3) 47- 34) 21(5) 29(22(6) 33(43) 49- 25) 50- 26- 17- 36(9,46- 13) 31(42) 23(7) 48- 26/h18- 26,28- 32,34,40- 42,44- 45H,14- 17H2,1- 13H3/t18- ,19- ,20+,21+,22- ,23+,24+,25- ,26+,28- ,29+,30- ,31+,32- ,34+,35- ,36- ,37- /m1/s1 |
ULGZDMOVFRHVEP-RWJQBGPGSA-N |
CC[C@H] 1OC(=O) [C@H] (C) [C@@H] (O[C@H] 2C[C@@] (C) (OC) [C@@H] (O) [C@H] (C) O2) [C@H] (C) [C@@H] (O[C@@H] 2O[C@H] (C) C[C@@H] ([C@H] 2O) N(C) C) [C@] (C) (O) C[C@@H] (C) C(=O) [C@H] (C) [C@@H] (O) [C@] 1(C) O |
|
environmental contaminant
Any minor or unwanted substance introduced into the environment that can have undesired effects.
(via erythromycin )
|
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
(via erythromycin )
xenobiotic
A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
(via erythromycin )
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via macrolide antibiotic )
|
|
View more via ChEBI Ontology
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)- 4- (2,6- dideoxy- 3- C- methyl- 3- O- methyl- α- L- ribo- hexopyranosyloxy)- 14- ethyl- 7,12,13- trihydroxy- 6- [3,4,6- trideoxy- 3- (dimethylamino)- β- D- xylo- hexopyranosyloxy]- 3,5,7,9,11,13- hexamethyloxacyclotetradecane- 2,10- dione
|
erythromycin
|
eritromicina
|
ChemIDplus
|
erythromycin
|
ChemIDplus
|
érythromycine
|
ChemIDplus
|
erythromycinum
|
ChemIDplus
|
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)- 6- {[(2S,3R,4S,6R)- 4- (dimethylamino)- 3- hydroxy- 6- methyltetrahydro- 2H- pyran- 2- yl]oxy}- 14- ethyl- 7,12,13- trihydroxy- 4- {[(2R,4R,5S,6S)- 5- hydroxy- 4- methoxy- 4,6- dimethyltetrahydro- 2H- pyran- 2- yl]oxy}- 3,5,7,9,11,13- hexamethyloxacyclotetradecane- 2,10- dione
|
IUPAC
|
3''-O-demethylerythromycin
|
ChemIDplus
|
Abomacetin
|
KEGG COMPOUND
|
erthromycin
Note: (2015-04-15) A relatively common (>22,000 hits on Google, April 2015) misspelling of erythromycin (>9 million hits). |
|
ChEBI
|
Erythromycin
|
KEGG COMPOUND
|
Erythromycin
|
ChEMBL
|
ERYTHROMYCIN
|
ChEMBL
|
Erythromycin A
|
KEGG COMPOUND
|
ERYTHROMYCIN A
|
PDBeChem
|
Erythromycin A
|
ChEMBL
|
Erythromycin C
|
KEGG COMPOUND
|
1048
|
DrugCentral
|
C01912
|
KEGG COMPOUND
|
CPD-13804
|
MetaCyc
|
D00140
|
KEGG DRUG
|
DB00199
|
DrugBank
|
ERY
|
PDBeChem
|
LMPK04000006
|
LIPID MAPS
|
LSM-3416
|
LINCS
|
US2823203
|
Patent
|
View more database links |
114-07-8
|
CAS Registry Number
|
KEGG COMPOUND
|
114-07-8
|
CAS Registry Number
|
ChemIDplus
|
1675-02-1
|
CAS Registry Number
|
ChemIDplus
|
75000
|
Beilstein Registry Number
|
Beilstein
|
75279
|
Reaxys Registry Number
|
Reaxys
|
|